Valuation : Guerbet

Market Cap 93.98M 109M 88.99M 80.66M 151M 10.42B 152M 1.06B 406M 5.3B 410M 401M 16.75B P/E 2026 *
-4.18x
P/E 2027 * 8.11x
Enterprise Value 470M 545M 445M 403M 756M 52.07B 760M 5.28B 2.03B 26.49B 2.05B 2B 83.71B EV / Sales 2026 *
0.61x
EV / Sales 2027 * 0.58x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.13%
1 day+6.63%
1 week+343.63%
Current month+333.29%
1 month+305.95%
3 months+235.17%
6 months+171.51%
Current year+134.90%
1 week 7.55
Extreme 7.55
33.45
1 month 7.5
Extreme 7.5
33.45
Current year 7.48
Extreme 7.48
33.45
1 year 7.48
Extreme 7.48
33.45
3 years 7.48
Extreme 7.48
39.7
5 years 7.48
Extreme 7.48
44.25
10 years 7.48
Extreme 7.48
90.5
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 52 22/11/2023
Change 5-day change 1-year change 3-year change Capi.($)
+6.63%+343.63% - - 109M
+0.73%-5.04%-33.47%-4.85% 12.56B
-2.07%-2.38%+11.37%+11.85% 4.13B
-3.46%-4.65%-47.31%-56.66% 1.21B
-2.76%-5.97%-44.61%-45.09% 1.07B
+0.43%-1.47%+10.70%+75.05% 1.05B
-1.47%-7.83% - - 954M
-2.35%-6.69%-41.47% - 953M
-4.21%-3.00%+29.66%+88.78% 489M
+1.23%+10.18%+78.38% - 330M
Average -0.73%-3.96%-4.59%+11.51% 2.53B
Weighted average by Cap. -0.47%-4.53%-21.40%-0.34%

Financials

2026 *2027 *
Net sales 764M 887M 723M 656M 1.23B 84.7B 1.24B 8.59B 3.3B 43.09B 3.33B 3.26B 136B 798M 926M 756M 685M 1.29B 88.51B 1.29B 8.98B 3.45B 45.03B 3.48B 3.4B 142B
Net income -35.8M -41.55M -33.9M -30.73M -57.64M -3.97B -57.93M -403M -155M -2.02B -156M -153M -6.38B 8.3M 9.63M 7.86M 7.12M 13.36M 920M 13.43M 93.34M 35.89M 468M 36.18M 35.38M 1.48B
Net Debt 376M 436M 356M 322M 605M 41.65B 608M 4.22B 1.62B 21.19B 1.64B 1.6B 66.95B 370M 430M 351M 318M 596M 41.06B 599M 4.16B 1.6B 20.89B 1.61B 1.58B 66.01B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
07/09/26 €7.550 +0.13% 4
04/09/26 €7.540 +0.53% 11
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.450EUR
Average target price
8.433EUR
Spread / Average Target
+13.20%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!